Regulatory in vitro genotoxicity testing exhibits shortcomings in specificity and mode of action (MoA) information. Thus, the aim of this work was to evaluate the performance of the novel MultiFlow V R assay composed of mechanistic biomarkers quantified in TK6 cells after treatment (4 and 24 hr): gH2AX (DNA double strand breaks), phosphorylated H3 (mitotic cells), translocated p53 (genotoxicity), and cleaved PARP1 (apoptosis). A reference dataset of 31 compounds with well-established MoA was studied using the MicroFlow V R micronucleus assay. A positive call was raised following the earlier published criteria from Litron Laboratories. In the light of our data, these evaluation criteria should probably be adjusted since only 8/11 (73%) nongenotoxicants and 18/20 (90%) genotoxicants were correctly identified. Moreover, there is a need for new in vitro tools to delineate the predominant MoA as in the MicroFlow V R assay only 5/9 (56%) aneugens and 4/11 (36%) clastogens were correctly classified. In contrast, the MultiFlow V R assay provides more in-depth information about the MoA and therefore reliably discriminates clastogens, aneugens, and nongenotoxicants. By using a labspecific, practical threshold for the aforementioned biomarkers, 10/11 (91%) nongenotoxicants and 19/20 genotoxicants (95%), 9/11 (82%) clastogens, and 8/9 (89%) aneugens were correctly categorized, suggesting a clear improvement over the MicroFlow V R . Furthermore, the MultiFlow markers were benchmarked against established methods to assess the validity of the data. Altogether, these findings demonstrated good agreement between the MultiFlow V R assay and the benchmarking methods. Finally, p21 may improve class discrimination given the correct identification of 4/4 (100%) aneugens and 2/5 (40%) clastogens. 
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INTRODUCTION
An important process in the risk assessment of drug candidates is the investigation of the genotoxic potential. Therefore, well-established in vitro mammalian cell tests are performed as part of the ICH S2(R1) test battery. Positive results indicate a genotoxic hazard which could stop further development of a drug. At this point, follow-up testing is needed to investigate potential modes of action (MoAs) and determine if genotoxicity is occurring at clinically relevant concentrations.
In the last decades, major limitations such as relatively low specificity (5number of true negatives/(number of true negatives 1 number of false positives)) and inadequate MoA information obtained from in vitro methods were demonstrated [Kirkland et al., 2005; EllingerZiegelbauer et al., 2009; Simon et al., 2014; Cheung et al., 2015] . As the assessment of genotoxicity has continued to evolve, supplemental assays have been developed to add to the current test battery to improve specificity and provide high throughput capacity as well as MoA information. For instance, specificity was enhanced by improving measurements of cytotoxicity (representing a critical parameter for assessing doseresponse relationships for positive calls) and optimized test protocols [Fellows et al., 2008 Hynes, 2010] . Another critical source for specificity is probably the choice of the cell type. Fowler et al. [2012] published data demonstrating that commonly used mammalian cell lines tend to have increased frequencies of misleading results compared to human cell lines which seem to be less prone to yielding misleading results given their p53-proficient status. Additionally, several papers were published, which deal with the topic "mammalian versus human cells" comprising the pros and cons of each used cell type [Honma and Hayashi, 2011; Topham et al., 2012; Whitwell et al., 2015] . Among these activities aimed toward improvement of available methods, several alternative in vitro tools are being investigated and developed to create more accurate and efficient approaches for providing sufficient molecular target information and further contributing to modern safety assessment [EllingerZiegelbauer et al., 2009; Birrell et al., 2010; Doktorova et al., 2014; Williams et al., 2015; Hendriks et al., 2016; Bryce et al., 2017] . One major driving force or motivation for exploring new in vitro tools is the precise identification of a genotoxicant's MoA. This can be justified by the growing interest in threshold concepts of genotoxic responses [Lutz, 1998; Bolt, 2003; Bailey et al., 2009; Crump, 2011; ICH, 2012; Bevan and Harrison, 2017] . Basically, genotoxic mechanism involves the interaction of compounds or their metabolites with DNA or non-DNA targets. A distinction is made between primary genotoxicants (aneugens and clastogens) and herein called nongenotoxicants, i.e. cytotoxicants causing secondary genotoxicity known to trigger misleading positive results [Walmsley and Billinton, 2011; Bryce et al., 2014] . Aneugens are known to modulate non-DNA targets, including the spindle apparatus, thereby leading to a malsegregation of chromosomes. In contrast, clastogens induce chromosome breaks by direct or indirect interaction with DNA. Consequently, the identification of a genotoxicant's MoA is essential to support the derivation of nonlinear dose-response metrics for the risk assessment of pharmaceuticals for human use [Gu erard et al., 2015] . Such nonlinear dose-responses, so-called threshold effects, were demonstrated for spindle poisons, topoisomerase II inhibitors, or DNA synthesis inhibitors [Parry et al., 2002; Lynch et al., 2003; Bolt et al., 2004; Cammerer et al., 2010; Elhajouji et al., 2011; ICH, 2015] .
In this context, the growing importance of mechanistic biomarkers suitable to justify nonlinear dose-response relationships is evident from recent advances in assay development.
Based on the well-known limitations of the standard test battery, Litron Laboratories developed a new in vitro flow cytometric assay to support drug development at early stages by obtaining more mechanistic insights for the unambiguous classification of aneugens, clastogens, and nongenotoxicants. The method allows the simultaneous measurement of the following mechanistic endpoints in human lymphoblastoid TK6 cells.
Phosphorylated H2AX. H2AX is a member of the H2A histone protein family and stabilizes the DNA. H2AX becomes rapidly phosphorylated on the serine at position 139 (gH2AX) following double strand breaks (DSBs) and has proven to be a sensitive DNA damage marker [Rogakou et al., 1998; Watters et al., 2009; Nikolova et al., 2014] . The MRN complex (Mre11-Rad50-Nbs1) recognizes this DNA damage and initiates a characteristic signaling pathway, which enhances the binding of ATM (Ataxia telangiectasia mutated) to DSBs. The ATM kinase phosphorylates H2AX into gH2AX and additional MRN complexes are recruited. This leads to a positive feedback loop and the amplification of the gH2AX-linked chromatin domain [Smart et al., 2011] . It has been increasingly observed that the induction of gH2AX is related to exposure to clastogens like etoposide (ETO) or mitomycin C [Smart et al., 2008; Harada et al., 2014] .
Phosphorylated H3. Histone H3 is one of several histone proteins of the chromatin in eukaryotic cells. During mitosis histone 3 becomes phosphorylated on the serine at position 10 (pH3) by Aurora B kinase resulting in the packing of DNA into chromatin. Spindle poisons such as the aneugens vinblastine (VB) or colchicine lead to an accumulation of cells in mitosis because of the mitotic delay [Monaco et al., 2005; Ando et al., 2014] .
Cleaved PARP1. Poly(ADP-ribose)polymerases (PARPs) have diverse functions in biological processes such as the modification of chromatin, repair of DNA single strand breaks, metabolism, mitosis, and apoptosis and comprise a family of 17 members. PARP1 is the most studied member of the family and one of the most common nuclear proteins [Langelier et al., 2014] . Early apoptosis as well as DNA repair is marked by activation of PARP1. Considerable damage can lead to an irreversible phase of apoptosis, which is characterized by proteolytic cleavage of PARP1 into two stabile fragments, initiated by caspase 3 and 7. Thus, PARP1 loses its catalytic activity. This pathway is characteristic for apoptosis and therefore could be established as a sensitive method to detect dead cells [Sonnenblick et al., 2015] .
Tumor protein p53. The phosphoprotein p53 is a wellknown tumor suppressor and is mutated in 50% of human cancers [Soussi et al., 2006; Olivier et al., 2010] . It has a key function in cellular response to genotoxic stress. Thus, it recognizes genomic damage and induces cell cycle arrest, thereby preventing damaged cells from proliferation. More than 150 target genes are up-or downregulated by p53 [Appella and Anderson, 2001] . The regulation of p53 activity is achieved by its abundance and posttranslational modification. Healthy cells have a low amount of p53 and its proteasome degradation is subject to ubiquitination via mainly the ubiquitin ligase MDM2 [Haupt et al., 1997] . The ubiquitination is inhibited as a response to cellular stress and serves to stabilize p53. Subsequently, it translocates to the nucleus as a transcription factor and stimulates the synthesis of cell cycle inhibitors to prevent replication of damaged genetic material. Environmental and Molecular Mutagenesis. DOI 10.1002/em The assessment of the MultiFlow V R assay was performed as part of a ring trial designed to evaluate the performance and transferability of the "new" test system based on these mechanistic markers.
In this work data generated by the new assay were compared with the established MicroFlow V R micronucleus test, as well as other methods using similar or the same biomarkers. In that way a direct comparison between the results was performed, verifying the ability of the new method to correctly categorize compounds as aneugens, clastogens, and nongenotoxicants.
In the present work, it was furthermore of interest to identify potential new biomarkers. One promising candidate is the cyclin-dependent kinase inhibitor p21. It was hypothesized that a new mechanistic endpoint could be used in addition to the existing ones to achieve a more accurate identification of genotoxicants.
Cyclin-dependent kinase inhibitor p21. Similar to p53, p21 may also be considered as a suitable marker for genotoxicity since it is induced by p53. Thus, it regulates DNA damage responses and inhibits the cell cycle in G1 or G2 phases [Gartel and Tyner, 2002; Chen et al., 2008] . In general, p21 levels are low during cell proliferation [Zhang et al., 1994] but upon genotoxic stress, p21 is either transcriptionally activated via p53, which leads to a p53-dependent overexpression, or p53-independent activation of p21 can occur [el-Deiry et al., 1993; Macleod et al., 1995] .
MATERIALS AND METHODS

Test Agents
Test compounds are shown in Table I . These compounds are well characterized and have different MoAs. The genotoxicants (clastogens and aneugens) and nongenotoxicants were selected from a list provided by Litron Laboratories. The top concentrations were based on ICH S2(R1) guideline recommendations (1 mM) and on OECD Test Guideline 487 (10 mM). All test compounds were dissolved in dimethyl sulfoxide (DMSO) (1%, v/v) before use.
Cell Culture and Treatments
In all studies, the human lymphoblastoid TK6 cell line (purchased from ATCC: CRL-8015) was used. This cell line has several advantages for genotoxicity studies, e.g., it is TK locus heterozygous, p53 competent and has a stable genome. The growth mode is in suspension in a humid atmosphere at 378C with 5% CO 2 . The cell cultures were maintained in RPMI-1640 Medium (ATCC) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin solution.
Consistent for all methods, on treatment day, cells were adjusted to 2 3 10 5 /ml and transferred in a volume of 100 ml in each well in round bottom 96-well plates. The addition of test substances was followed in a volume of 100 ml. For treatments with the promutagens benzo[a]pyrene (BP) and cyclophosphamide (CP), exogenous metabolic activation is required. This was conducted using 2% rat liver S9 mix (Bayer AG). For these experiments, cells were exposed to chemicals and S9 mix for 4 hr, which were subsequently washed to remove the test article and S9. In general, the exposure time points and sample processing were performed early (4 hr) and late (24 hr) at prescribed concentrations (Tables   I and II) in a humidified atmosphere at 378C with 5% CO 2 . In the case of micronuclei (MN) scoring, an expression time of at least 1.5-2.0 cell cycles before assessment (20 hr) was employed. Figure 1 provides an overview of treatment and sampling.
The MultiFlow
V R Method
To identify genotoxic MoA and further discriminate among three classes, the "MultiFlow V R " kit (Litron Laboratories, Rochester, NY) was used to prepare nuclei for flow cytometric analysis.
The basis of the method is the concurrent release of nuclei along with fluorescence labeling for studying the following endpoints:
1. RNase and propidium iodide (cell cycle and polyploidy), 2. anti-gH2AX-Alexa Fluor V R 647 (DNA DSBs), 3. anti-phospho H3-PE (mitotic cells), 4. anti-p53-FITC (N-terminal domain of p53) (genotoxicity), or 5. cleaved PARP1-Alexa Fluor V R 647 (apoptosis).
Latex microspheres (Spherotech, Lake Forest, IL) provided as part of the MultiFlow V R kit served as "counting beads" and were used to determine nuclei density and further to calculate the % cytotoxicity (100 -relative nuclei count).
At 4 and 24 hr, exposed cells were resuspended and 25 ml were removed from each well and added to a new 96-well plate, which contained 50 ml prepared working MultiFlow V R assay solution. As listed above, the working solution comprises components to digest cytoplasmic membranes, stain chromatin and label each of the mechanistic endpoints at the same time [Bryce et al., 2016] . The analysis by flow cytometry (BD Accuri TM C6, BD Biosciences, San Jose, CA or MACSQuant V R , Miltenyi Biotec, Bergisch Gladbach, Germany) took place after 30 min incubation at room temperature with the working solution. With regard to data interpretation, Litron Laboratories generated standardized Excel spreadsheets and shared it with each cooperating lab. This ensures uniformity in order to calculate the fold increases of biomarker changes above solvent control. The interlab study was based on three stages and was composed of experimental designs with various model compounds as well as concentration ranges and the resulting data were shared with Litron Laboratories. For our investigation, a set of 31 model compounds was analyzed. The main difference across the studies concerns stage 3, when the endpoint cleaved PARP1 was replaced by nuclear-translocated p53. Thus, some chemicals were run with cleaved PARP1 and other with p53 which is shown in more detail in Table I .
Statistical Analysis of the MultiFlow V R Endpoints
The receiver operating characteristic (ROC) curve for each individual endpoint/time point was calculated using GraphPad Prism (v7.0). Based on these ROC curves, thresholds were set for compound-induced effects on biomarkers pointing to clastogenic-(gH2AX), aneugenic-(pH3) and genotoxic-(p53) signature. Furthermore, the ROC curves were used to determine which time point is useful for class discrimination. As reported previously, the use of these biomarkers achieves a good sensitivity at cytotoxicity up to 80% without compromising specificity [Bryce et al., 2016] . Thus, data that resulted in >80% cytotoxicity (RNC) were excluded from analysis.
Traditional Screening Tests Versus the Novel MultiFlow
The purpose of these experiments was to compare the results of the MultiFlow V R assay with an established genotoxicity screening assay and single-read test systems. As comparable methods, the in vitro MNT, single-read biomarker methods on high content imager and commercially available assays like the APO-BrdU TUNEL and Caspase 3/7 kits were (Table I) .
Scoring of Micronuclei in the In Vitro MicroFlow
V R Assay
Human TK6 cells were treated for 4 and 24 hr in 96-well plates. Different from the MultiFlow V R and the other validation methods, the 4 hr samples needed a recovery time of at least 1.5-2.0 cell cycles before Environmental and Molecular Mutagenesis. DOI 10.1002/em assessment. Thus, the cells were washed after 4 hr, centrifuged twice (80 g, 5 min), resuspended in fresh growth medium and returned to the incubator for additional 20 hr. Finally after a total of 24 hr, samples were processed in accordance with the manual of the MicroFlow V R Assay (Litron Laboratories). The method is based on:
1. DNA labeling of necrotic and mid/late apoptotic cells (ethidium monoazide, EMA), 2. lysing of cells to liberate nuclei, and 3. exposure of nuclei/MN to RNase, nucleic acid dye (SYTOX green) to quantify healthy nuclei and identify MN.
Samples were analyzed by flow cytometer BD Accuri TM (BD Biosciences) and were limited to 3000 gated nuclei events with a sample volume of 150 ml. The scored plots provided information on intact cells, apoptotic/ necrotic cells, nuclei-to-bead ratio (cytotoxicity assessment), MN and hypodiploid nuclei (HD). Marked increases of HD (>10-fold above the mean control) may point to an aneugenic MoA [Bryce et al., 2011] . The test was considered positive if the compound achieved a 3-fold increase of MN [Bryce et al., 2014] relative to vehicle control (1% DMSO) at concentrations with >50 6 5% cell survival (relative nuclei count, RNC).
Automated Fluorescence Imaging
At 4 and 24 hr postexposure, 96-well plates were centrifuged (80 g, 5 min), washed once with growth medium and centrifuged repeatedly. Next, the cells were fixed with ice-cold methanol at 2208C for 10 min, centrifuged (80 g, 5 min.) and permeabilized for 5 min with 0.1% Triton-X in PBS. Permeabilized cells were incubated for 1 hr at 378C with primary antibodies obtained from Bethyle Lab., Montgomery (antigH2AX, A300-081A; anti-pH3, A301-844A) followed by a 30 min incubation at 378C with a secondary antibody labeled with Alexa Flour 488 (Thermo Fisher, Rockford, USA). The nuclei were stained with DAPI (NucBlue V R Fixed Cell ReadyProbes V R Reagent, Molecular Probes, Darmstadt, Germany) and analyzed by high content imaging (ImageXpress V R Micro XLS System, Molecular Devices, LLC, Sunnyvale, CA). The software MetaXpress V R (Version 5.3.0.4, Molecular Devices) provides the option for image analysis.
The ready-made application module "multi wavelength cell scoring" was used to score the total nuclear fluorescence of gH2AX and pH3. Afterward, Microsoft Excel was applied to calculate the fold change relative to the solvent control. The assessment of the MultiFlow V R endpoints against the alternative single-read methods was conducted with linear regression (R square) in GraphPad Prism (v7.0).
The APO-BrdU TM TUNEL Assay
The APO-TUNEL Assay (Thermo Fisher) was performed to validate the data of the apoptosis marker "cleaved PARP1" generated by the MultiFlow V R kit. The basic principle of the TUNEL method is the labeling of 3 0 OH ends of DNA in late apoptotic cells by the use of exogenous terminal deoxynucleotidyl transferase (TDT) in addition of the deoxythymidine analog 5-bromo-2 0 -deoxyuridine 5 0 -tri-phosphate (BrdUTP).
At 4 and 24 hr, samples in 96-well plates were centrifuged (80 g, 5 min), washed once with growth medium, and centrifuged repeatedly. Processed cells, according to manufacturer instructions, were analyzed by flow cytometry using a MACSQuant V R Analyzer 10 (Miltenyi Biotec) and afterward calculated as fold increase relative to the solvent control. The evaluation of the MultiFlow V R endpoint cleaved PARP1 against BrdU was conducted with linear regression (R square) in GraphPad Prism (v7.0).
The LIVE Red Caspase-3 and -7 Detection Assay
In order to improve sensitivity both apoptosis markers, caspase-3 and -7, were assessed by Image-iT V R LIVE Red Caspase-3 and -7 Detection Kit (Applied Biosystems, Darmstadt, Germany) to compare to cleaved PARP1. At 4 and 24 hr, samples in 96-well plates were centrifuged (80 g, 5 min), washed once with growth medium, and centrifuged repeatedly. Next, the cells were incubated with the caspase 3/7 detection reagent for 1 hr at 378C and then fixed with ice-cold methanol at 2208C for 10 min. Nuclei were stained with DAPI (NucBlue V R Fixed Cell ReadyProbes Environmental and Molecular Mutagenesis. DOI 10.1002/em ImageXpress V R Micro XLS System (Molecular Devices). The ready-made application module "multi wavelength cell scoring" was applied to count the total nuclear fluorescence of caspase 3/7. A comparison of both markers was performed by linear regression (R square) in GraphPad Prism (v7.0). Table II (CAS and reference as Table I ) lists the compounds tested for investigation of p21 protein levels. The test chemical concentrations (low, middle, and high) were based on the separately generated MNT data whereby the highest concentration did not exceed >60% cytotoxicity. Pierce BCA Protein Assay (Thermo Fisher) was applied to determine total protein content of TK6 cells at 4 and 24 hr. The samples were processed by the manufacturer specifications and analyzed using a Spectra Max V R plate reader (Molecular Devices). Next, the total protein content was adjusted to 100 mg/ml and immediately the enzyme-linked immunosorbent assay (human p21 ELISA, Abcam, Cambridge, UK) was performed. Table III highlights the results from biological replicates and the classification profiles of 31 tested compounds. The MN frequencies were used to calculate fold increases relative to solvent control. The evaluation criteria for relevant increases of MN or HD were based on publications of Litron Laboratories [Bryce et al., 2011 [Bryce et al., , 2014 in consideration of cytotoxicity (<55 6 5%; RNC).
The ELISA Test for Investigating p21Changes
RESULTS
Identification of Genotoxic Agents Using the In Vitro MicroFlow Method
All tested aneugens, nocodazole (NOC), mebendazole (MEB), diethylstilbestrol (DES), AMG-900, carbendazim (CBD), griseofulvin (GF), VB, noscapine (NOS), and paclitaxel (PT) significantly induced the formation of MN in both replicates over solvent controls. As with aneugens, all The fold changes of HD did not clearly support the discrimination of clastogens and aneugens. The aneugens DES, MEB, AMG-900, and NOS did not induce marked increases in the frequency of HD, whereas the nongenotoxicant TC and the clastogens CS, 4-NQO, 5-FU, MMS, HU, CTH, and CP caused >10-fold increases and were classified as aneugens.
Identification of Genotoxicity by the MultiFlow
V R Method Figure 2 demonstrates the contribution of each biomarker to class discrimination.
Performance of pH3. An increase of pH3 activity is associated with aneugenic effects (Fig. 2A,B) and showed markedly higher responses to all aneugens except for (<80%) and data points represent each tested concentration using up to 31 compounds. Control is represented by the black line and the dashed line is for calculated threshold. Aneugens 5 blue points, clastogens 5 red points, and nongenotoxicants 5 gray points.
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Classification of In Vitro Genotoxicants
AMG-900 (4 hr) and GF (24 hr) that showed a decrease of pH3. At both time points, the clastogens CP (4 hr) and H 2 O 2 (24 hr) modestly affected pH3. All other clastogens did not show an increasing effect on pH3, but rather revealed a decrease of pH3.
Performance of cH2AX. Increased gH2AX events suggest clastogenicity (Fig. 2C,D) . At both time points, all clastogens caused an increase of gH2AX levels with the exception of 5-FU (4 hr) and HU (24 hr). Additionally, the nongenotoxicants TG (at 4 hr) and CCCP (at 24 hr) showed a gH2AX response at the highest concentrations. Aneugens did not significantly affect gH2AX levels.
Performance of p53. The endpoint p53 is indicative for genotoxic stress in cells. Some clastogens led to an increase of p53 at early (Fig. 2E) and some clastogens as well as aneugens at late (Fig. 2F ) time points. The clastogen EMS did not significantly increase p53. Almost all nongenotoxicants showed no effect on genotoxic stress, Environmental and Molecular Mutagenesis. DOI 10.1002/em except for imatinib that displayed a marked p53 response at the early time point.
Polyploidy. Polyploidy assessment at 4 hr did not allow for any conclusions regarding aneugenic signature (Fig.  2G) . Later assessment of polyploidy showed increases in each different MoA group (Fig. 2H) . Besides the aneugens (AMG-900, NOS, CBD, and VB) also the nongenotoxicants (brefeldin-A, CCCP, and TC) and the clastogens (ETO and H 2 O 2 ) induced polyploidy.
Performance of cleaved PARP1. Apoptosis occurred already after 4 hr (Fig. 2I ) and increased at 24 hr (Fig. 2J ) in a compound-specific manner. At 4 hr, the nongenotoxic compound CCCP showed the most distinct effect on cleaved PARP1 followed by TG, TC as well as the clastogens ETO and the aneugen GF. At late time points, almost all compounds induced apoptosis evident from PARP cleavage with the exception of imatinib.
Evaluation of the MultiFlow V R Endpoints
The optimal time point for each endpoint as well as the following threshold values for gH2AX, pH3 and p53 were derived from ROC curve analyzed as follows: 24 hr cH2AX: 9/11 clastogens displayed a gH2AX response (5-FU and HU missed), 4 hr pH3: 8/9 aneugens increased pH3 (AMG-900 missed), and 4 and 24 hr p53: 6/7 clastogens (EMS missed) and 5/5 aneugens were identified as genotoxicants.
An unexpected result was obtained for the nongenotoxicant imatinib (p53 response). The practical thresholds for the endpoints gH2AX (24 hr: 1.89), pH3 (4 hr: 2.91), and p53 (4 hr: 1.57; 24 hr: 1.68) were based on a 99% probability for categorization into one of the three classes (aneugen, clastogen, and nongenotoxicant). Environmental and Molecular Mutagenesis. DOI 10.1002/em
Classification of In Vitro GenotoxicantsComparison Between Multiplex and Single-Read Marker Methods
Taken together, the results display a good agreement between multiplexed flow cytometric endpoints and single-read markers from alternative methods.
The comparison of pH3 between flow cytometry and high content imaging showed a very good concordance (Fig. 3A) . Thus, assessment of pH3 in a multiplex method seems to be very sensitive.
Regarding gH2AX, the methods matched after 4 hr assessment of DNA DSB, but got imprecise after 24 hr (Fig. 3C) .
The concordance between the apoptosis markers cleaved PARP1 and caspase 3/7 was low since there was no sufficient correlation between the methods detectable (Fig. 3E) .
The correlation between PARP1 and BrdU (APO-TUNEL) showed no concordance (Fig. 4B) . The APO TUNEL method detected a strong apoptotic response of the nongenotoxic compound CCCP (Fig. 4C) .
Measurement of the Protein Concentration of p21by ELISA
It was investigated whether the compounds (Table II) induce dose-response changes in p21 protein levels after 4 and 24 hr and may support class discrimination. The results are shown in Figure 5 . The dashed line represents the negative control (1% DMSO). The nongenotoxic compounds CCCP and ofloxacin induced no changes in p21 protein levels at both time points. Imatinib showed a moderate p21 activity at the lowest concentration. At early time points genotoxicity was just observed after treatment with the clastogen 5-FU. After 24 hr, p21 protein levels increased for most genotoxic compounds 6/9 (67%).
DISCUSSION
Methods for the assessment of genotoxicity have undergone multiple changes during the last decades. Published data have reported several sources of limitations (e.g., specificity or MoA information). Consequently, many activities to counteract these limitations have started: well-established in vitro methods have been modified and improved. Additionally, many new in vitro tools are being explored and developed. One of those is the MultiFlow V R assay developed by Litron Laboratories which seems promising to achieve higher specificity and provide relevant MoA information aimed to discriminate among three MoA groups: aneugens, clastogens, and nongenotoxicants. Thus, in this work, the performance of the new method was assessed by a direct comparison of the results of the in vitro MNT screening assay (MicroFlow V R , Litron Laboratories) and new multiplexed method (MultiFlow V R , Litron Laboratories).
Classification of In Vitro Genotoxicants Using WellEstablished Screening and Exploratory Methods
The flow cytometric MN assay (MicroFlow V R ) was considered positive if a 3-fold increase in MN frequency was observed compared to the solvent control [Bryce et al., 2014] . Our findings revealed that two genotoxic compounds (H 2 O 2 and BP) were judged inconclusive and three nongenotoxicants (CCCP, TG, and TC) were tested positive and therefore represented the frequently misleading positives in the MNT due to secondary effects [Walmsley and Billinton, 2011; Bryce et al., 2014; Cheung et al., 2015] . For these studies, cytotoxicity measurements were based on RNC that has been shown to (Table II) . Black 5 genotoxicants and gray 5 nongenotoxicants.
underestimate cytotoxicity compared to relative population doubling (RPD) or relative increase in cell count (RICC) [Fellows et al., 2008; Galloway et al., 2011] . Therefore, using the RPD or RICC may have turned their classification to negative. Consequently, it should be studied in more detail if the primary cytotoxicity parameters according to OECD TG 487, i.e. RICC or RPD would have been more appropriate than RNC.
In addition, BP was not clearly identified as genotoxic since it induced just a weak 3.25 MN-fold increase in only one experiment. As for BP, H 2 O 2 -induced MN were observed in only one of the two independent replicates. Thus, inconclusive results were yielded by using the criteria of Litron Laboratories for a positive call (3 fold increase of MN at concentrations with >50 6 5% cell survival based on RNC). In the light of our data, it can be suggested that the criteria for a positive call might be reevaluated, e.g., by using the criteria stated in the OECD 487 guidance (2016) (at least one statistically significant increase of MN above the negative control, dose relationship, outside the historical control range) to obtain all true positives. Considering our historical control data and statistics, the unclear compounds would have been clearly positive. Further, a dose-response relationship was established. Thus, overall, the adjusted evaluation criteria would end up in an unequivocal result.
Furthermore, the automated MN assay provides scoring of chromosome loss-derived nuclei, so called HD that may help to identify aneugens, thus being useful to distinguish between clastogens and aneugens [Bryce et al., 2010; Cheung et al., 2015] . HD responses were considered positive by a robust >10-fold increase compared to the solvent control. However, this was not observed in all evaluated aneugens (5/9). Notably, significant increases were also observed for 7/11 clastogens and for the nongenotoxic compound TC (Table III) . At this point, it should be investigated whether the timing to capture HD is appropriate and perhaps later time points would have been more useful. This assumption is based on Shi et al. [2010] who showed robust increases of HD in TK6 cells after 28 hr treatment with four well-known aneugens.
Litron Laboratory's multiplex approach-the "MultiFlow
Assay" comprises endpoints relating to genotoxic responses: DNA DSBs (gH2AX), mitotic cells (pH3), apoptotic cells (cleaved PARP1), or genotoxicity (p53) [Bryce et al., 2016] . The evaluation of the genotoxic markers was conducted by performing ROC analyses and based on data up to 80% cytotoxicity (RNC) at 24 hr. The work of Bryce et al. [2016] demonstrates that the high cytotoxicity limits do not affect the specificity of the assay and improves the categorization among these compound groups. This is in agreement with our data. The categorization into clastogens using the biomarker gH2AX performed best after 24 hr and resulted in the correct classification for 9/11 clastogens. Notably, 5-FU caused no significant increase in gH2AX at both time points and HU showed a decrease in gH2AX at 24 hr while both compounds showed clear p53 responses that support classification into genotoxic MoA. This suggests that for antimetabolites different treatment schedules in TK6 cells have to be considered and required further investigations.
As seen in Figure 2A , increases in pH3 were characteristic for aneugens after 4 hr exposure, while the aneugen AMG-900 caused no increase in pH3. This can be justified through its MoA. AMG-900 is a pan-Aurora kinase inhibitor, which affects mitosis [Terada et al., 1998; Sampath et al., 2004] . The phosphorylation of histone H3 is mediated by Aurora B kinase and AMG-900 can inhibit its action [Juan et al., 2014] . The clastogenic compounds CP and BP slightly affected pH3 but showed mainly an increase in gH2AX (Fig. 2C,D) . This suggests that the predominantly clastogenic compounds interfere with cell cycle kinetics by other mechanism as common aneugens and therefore increase pH3. Published works of Stellas et al. [2014] and Aguilar-Mahecha et al. [2005] provide evidence that these compounds cause cell cycle arrest due to drastic genetic damage effects. In total, 8/9 model aneugens yielded correct calls due to marked pH3 increases. Furthermore, the assessments of polyploidy did not provide definitive class discrimination (Fig. 2H) . The observed findings are consistent with generated data of the MNT in this work as well as the literature [Shi and King, 2005] demonstrating that human cell lines more likely induce tetraploid nuclei instead of polyploidy. Another reason for this observation could be the timing to monitor polyploidy. Thus, in a previous study using a recovery time of 12 hr after 24 hr continuous treatment, an optimal polyploidy response by the aneugenic compound fisetin was reported [Gollapudi et al., 2014] .
The tumor suppressor gene p53 is generally low in cells, but genotoxic stress triggers p53 translocation to the nucleus [Yang and Duerksen-Hughes, 1998 ]. Results from p53 analyses demonstrate a modest increase after the treatment with clastogens for 4 hr (Fig. 2E) , whereas a robust increase with clastogens and aneugens could be observed after 24 hr (Fig. 2F) . Therefore, almost all genotoxic candidates could be classified correctly by p53, in contrast to the nongenotoxic compound imatinib and the clastogen EMS. Imatinib was accidentally classified as genotoxic compound in the MultiFlow V R assay due to increasing p53 levels while no increases in gH2AX and pH3 were observed. EMS did not show a robust p53 response at both time points while clear induction of gH2AX was observed supporting the classification into clastogenic MoA. Nevertheless, the addition of p53 seems to be a meaningful extension of the MultiFlow V R method since this biomarker helped to correctly identify almost all studied genotoxicants (11/12), even those that were not detectable by gH2AX (5-FU) and pH3 (AMG-900). Therefore, the inclusion of the biomarker p53 provides an improvement to obtain mechanistic insights Environmental and Molecular Mutagenesis. DOI 10.1002/em into genotoxicity useful to discriminate genotoxicants from nongenotoxicants. However, misleading results were obtained for some compounds, as in the MNT.
In order to validate the multiplex approach, the MultiFlow endpoints were compared with single-endpoint immunofluorescence assays read by automated image analysis system. For the assessment of gH2AX and pH3, the same assays were applied, while for cleaved PARP1 other apoptosis markers and methods, namely caspase 3/7 and the TUNEL method were assessed (Figs. 3 and 4) . The flow cytometric assessment of DNA DSBs is more sensitive than the automated image analysis. The 4 hr comparisons of the methods displayed a good agreement (R 2 5 0.88) but gets imprecise after including the 24 hr data (R 2 5 0.59). This could be due to different analysis processes. The flow cytometric method enables the exclusion of highly resolved gH2AX-positive nuclei generated by apoptotic cells [Bryce et al., 2016] . Further, the comparison of early apoptosis markers exhibits a weak correlation. Caspase 3/7 cleaves PARP1, thus this relationship supports our observation of modest endpoint agreement [Walsh et al., 2008] . The generated apoptosis data demonstrate that cleaved PARP1 is very sensitive to measure early apoptosis stages whereas the incorporation of BrdUTP in the APO-BrdU TUNEL assay is related to late apoptosis (cleaved DNA) resulting in no agreement between the methodologies. Additionally, it cannot be ruled out that necrotic cells are also captured in the APOBrdU TUNEL assay [Grasl-Kraupp et al., 1995] . Nevertheless, the method is useful to identify strong apoptosisinducing compounds like CCCP, an uncoupling and depolarizing agent that affects mitochondria [Hinz et al., 1999; Bondi et al., 2015] . Collectively, it is noticeable that the multiplexed method generates reliable data, is much more sensitive in some points and samples can be collected very rapidly compared to single-endpoint assessment.
Finally, there is a continuing need to identify additional mechanistic biomarkers. Besides p53, a possible alternative endpoint for the detection of genotoxicants is p21 that was studied using ELISA. All in all, the results for p21 were in line with those of p53 Nevertheless, p21 cannot replace nuclear p53 as a mechanistic biomarker for the following reasons: Induction of p21 was observed in 4/4 aneugens and 2/5 clastogens (Fig. 5B) suggesting that the concentration selection, the time point or decision of endpoint might not have been optimal. As in the case of p53, the nongenotoxic compound imatinib triggered a p21 response, but noticeably lower than p53.
CONCLUSIONS
Our findings point to significant differences between the in vitro MicroFlow and the novel MultiFlow V R method with respect to their ability to discriminate nongenotoxicants, aneugens, and clastogens. Unquestionably, the flow cytometric MNT yielded the correct identification of 18/20 (90%) genotoxicants while 3/11 (27%) of nongenotoxicants were misclassified based on Litron's published evaluation criteria. In contrast, the MultiFlow correctly identified 19/20 (95%) genotoxicants and showed a clearly superior ability to discriminate between nongenotoxic, clastogenic, and aneugenic substances evident from the percentage of correct classifications (MNT: clastogens 4/11 (36%), aneugens 5/9 (56%); MultiFlow V R : clastogens 9/11 (82%), aneugens 8/9 (89%). This suggests that the information gained from the mechanistic biomarkers gH2AX, pH3 and activated p53 was more relevant for class discrimination than the frequency of MN and HD determined in the in vitro MicroFlow V R . Data of p21, which is based on protein levels, demonstrate that this biomarker alone cannot reliably detect genotoxicants. Other possible areas of research for identifying new mechanistic markers are epigenetic effects, i.e., histone modifications and/or activated proteins. This work also demonstrated that during the development of new assays, the biomarkers that are relevant for class discrimination should be chosen based on the known molecular mechanisms underlying the different phenotypes being addressed. For instance, the aneugen AMG-900 differs from the other aneugens with respect to its MoA and was therefore classified incorrectly. Moreover, the expansion of the reference dataset, the exploration of other time points and molecular markers and the application of a multinomial logistic regression approach (combination of endpoints, e.g., p53 plus gH2AX or pH3 plus polyploidy) as prediction tool may be useful to further enhance the predictive power of the method. The machine learning approach used by the investigators was useful for instance to categorize 5-FU as clastogen [Bryce et al., 2017] . Finally, based on our results, the new method promises to be an efficient and capable multiplexed in vitro tool for better risk assessment and continues to be a platform for innovative research.
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